Alliances
The two companies will work to develop up to four preclinical compounds discovered by Sitryx for autoimmune diseases.
Collaboration with Silence Therapeutics aims to develop novel, targeted treatments to address significant unmet need
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2020.
The two companies plan to focus their efforts on targeting several rare diseases.
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
Sanofi Pasteur and Translate Bio have partnered to develop a novel messenger RNA vaccine for COVID-19, the disease caused by the novel coronavirus.
Specifically, they will be looking at ways to improve processes by speeding up and reducing the cost of manufacturing.
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
Under terms of the agreement, Astellas will make an upfront cash payment of $80 million to CytomX.
The two companies will focus on BioNTech’s BNT162, an mRNA-based vaccine candidate.
PRESS RELEASES